COVID-19 vaccines in patients with urothelial cancers receiving immune checkpoint inhibitors.

被引：0
|
作者：
Gilbert, Danielle
Hu, Junxiao
Lam, Elaine T.
机构：
[1] Univ Colorado, Sch Med, Aurora, CO USA
[2] Univ Colorado, Ctr Canc, Aurora, CO USA
[3] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
491
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Immune-checkpoint inhibitors from cancer to COVID-19: A promising avenue for the treatment of patients with COVID-19 (Review)
    Vivarelli, Silvia
    Falzone, Luca
    Torino, Francesco
    Scandurra, Giuseppa
    Russo, Giulia
    Bordonaro, Roberto
    Pappalardo, Francesco
    Spandidos, Demetrios A.
    Raciti, Giuseppina
    Libra, Massimo
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2021, 58 (02) : 145 - 157
  • [32] Immune checkpoint alterations and their blockade in COVID-19 patients
    Tan, Jiaxiong
    Li, Yangqiu
    BLOOD SCIENCE, 2022, 4 (04): : 192 - 198
  • [33] Nephrotoxicity in patients with cancer treated with immune checkpoint inhibitors.
    Papaiakovou, Evangelos Eleutherakis
    Kastritis, Efstathios
    Zagouri, Flora
    Grapsa, Dimitra
    Ntanassis-Stathopoulos, Ioannis
    Stefanou, Dimitra
    Evangelou, Georgios
    Kotteas, Ilias
    Dimopoulos, Meletios A.
    Syrigos, Konstantinos
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Immune Responses Of CVID Patients To COVID-19 Vaccines
    de Medeiros, Giuliana Xavier
    Ferreira, Loisi de Carvalho Pereira
    Magawa, Jhosiene Yukari
    Kuramoto, Andreia
    Sasahara, Greyce Luri
    Ferreira, Marcelo
    Toledo Barros, Myrthes Maragna
    Kalil, Jorge
    Barreto Berselli Marinho, Ana Karolina
    Cunha-Neto, Edecio
    Santos, Keity Souza
    Kokron, Cristina
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB24 - AB24
  • [35] TERT promoter mutation as a prognostic marker in patients with advanced urothelial carcinoma treated with immune checkpoint inhibitors.
    de Kouchkovsky, Ivan
    Zhang Li
    Philip, Errol
    Wright, Francis
    Kim, Daniel Myung
    Natesan, Divya
    Kwon, Daniel
    Ho, Hansen
    Ho, Son
    Chan, Emily
    Porten, Sima P.
    Desai, Arpita
    Huang, Franklin W.
    Chou, Jonathan
    Oh, David Yoonsuk
    Pruthi, Raj
    Fong, Lawrence
    Small, Eric Jay
    Friedlander, Terence W.
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [36] AKI in Patients Receiving Immune Checkpoint Inhibitors
    Perazella, Mark A.
    Sprangers, Ben
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2019, 14 (07): : 1077 - 1079
  • [37] Genomic and Clinical Prognostic Factors in Patients With Advanced Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors
    Chawla, Neal S.
    Sayegh, Nicolas
    Tripathi, Nishita
    Govindarajan, Ameish
    Zengin, Zeynep B.
    Phillip, Errol J.
    Dizman, Nazli
    Meza, Luis
    Muddasani, Ramya
    Chehrazi-Raffle, Alexander
    Malhotra, Jasnoor
    Hsu, JoAnn
    Agarwal, Neeraj
    Pal, Sumanta K.
    Tripathi, Abhishek
    CLINICAL GENITOURINARY CANCER, 2023, 21 (01) : 69 - 75
  • [38] Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors
    Bersanelli, Melissa
    IMMUNOTHERAPY, 2020, 12 (05) : 269 - 273
  • [39] Vaccines and immune checkpoint inhibitors: a promising combination strategy in gastrointestinal cancers
    Bashir, Babar
    Flickinger, John C.
    Snook, Adam E.
    IMMUNOTHERAPY, 2021, 13 (07) : 561 - 564
  • [40] A Single Center Retrospective Study of the Impact of COVID-19 Infection on Immune-related Adverse Events in Cancer Patients Receiving Immune Checkpoint Inhibitors
    Guo, Mengni
    Liu, Jieying
    Miao, Ruoyu
    Ahmed, Zohaib
    Yu, James
    Guan, Jian
    Ahmad, Sarfraz
    Zhou, Shuntai
    Grove, Angela
    Manoucheri, Manoucher
    Socinski, Mark A.
    Mekhail, Tarek
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (09) : 389 - 395
12345